Código 300320 (Harmonized System 2012 by 6 digits)
In 2024, the main commercial destinations of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were Brazil (US$203k), Guatemala (US$121k), Costa Rica (US$53.5k), and Nicaragua (US$14.5k).
The main commercial origins of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) in 2024 were China (US$11.7M), India (US$2.19M), Brazil (US$1.47M), Taiwan (Region) (US$655k), and Pakistan (US$337k).
In the global context, the main exporting countries of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) in 2022 were China (US$289M), Italy (US$269M), and Jordan (US$44.6M). In the same year, the main importing countries of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were Switzerland (US$210M), United States (US$57.1M), and Germany (US$47.2M).
The visualizations show the net balance of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
2026-Q2: US$325k, International Sales
The visualization shows the quarterly concentration of international sales of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) at state level.
In the second quarter of 2026, international sales were US$325k, being the states with the most sales Jalisco (US$325k).
Brazil: US$203k, Main commercial destination (2024)
In 2024, the countries with the most international purchases from Mexico were Brazil (US$203k), Guatemala (US$121k), Costa Rica (US$53.5k), and Nicaragua (US$14.5k).
China: US$11.7M, Main Commercial Origin (2024)
The countries with the most international sales to Mexico in 2024 were China (US$11.7M), India (US$2.19M), Brazil (US$1.47M), Taiwan (Region) (US$655k), and Pakistan (US$337k).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof). On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof). In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were China (US$289M), Italy (US$269M), and Jordan (US$44.6M). In the same year, the main importing countries for Medicaments Containing Antibiotics, not in Measured Doses or put up for Retail (Exc. Containing Penicillins or Derivatives Thereof with a Penicillanic Acid Structure or Streptomycins or Derivatives Thereof) were Switzerland (US$210M), United States (US$57.1M), and Germany (US$47.2M).